Ajay Singh Rawat

Title: Ajay Singh Rawat: Innovator in Pharmaceutical Chemistry

Introduction

Ajay Singh Rawat is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel crystalline forms of clopidogrel, a platelet aggregation inhibitor. His work has implications for the treatment and management of various cardiovascular disorders.

Latest Patents

Ajay Singh Rawat holds a patent for "Crystalline polymorphs of clopidogrel." This invention relates to novel crystalline forms of clopidogrel in the form of hydrogen bromide salts, identified as polymorph forms 1, 2, and 3. The patent also details processes for preparing these forms, pharmaceutical compositions that include them, and their uses in inhibiting platelet aggregation. These compositions are particularly useful for treating conditions such as thrombosis, atherothrombosis, ischemic stroke, myocardial infarction, and unstable angina.

Career Highlights

Throughout his career, Ajay Singh Rawat has worked with prominent companies in the pharmaceutical sector, including Generics (UK) Limited and Generics Limited. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Ajay has collaborated with notable professionals in his field, including Ramakrishnan Arul and Maheshkumar Gadakar. These collaborations have further enhanced his research and development efforts in pharmaceutical innovations.

Conclusion

Ajay Singh Rawat is a distinguished inventor whose work in pharmaceutical chemistry has the potential to significantly impact the treatment of cardiovascular diseases. His innovative approach to developing crystalline forms of clopidogrel showcases his commitment to advancing medical science.